Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 24859

Original article / research
Year : 2016 | Month : May | Volume : 10 | Issue : 5 | Page : OC17 - OC20

Factors Contributing to Development and Reversal of LVH: A Pilot Study

Prasanna Kumar Hassan Ramaswamy, M. Bhanukumar, Basavanagowdappa Hathur, K.C. Shashidhara, K.M. Srinath

1. Assistant Professor, Department of Medicine, JSS Medical College & Hospital, JSS University, Mysore, Karnataka, India. 2. Associate Professor, Department of Medicine, JSS Medical College & Hospital, JSS University, Mysore, Karnataka, India. 3. Professor, Department of Medicine, JSS Medical college & Hospital, JSS University, Mysore, Karnataka, India. 4. Associate Professor, Department of Medicine, JSS Medical College & Hospital, JSS University, Mysore, Karnataka, India. 5. Associate Professor, Department of Medicine, JSS Medical College & Hospital, JSS University, Mysore, Karnataka, India.

Correspondence Address :
Dr. Prasanna Kumar Hassan Ramaswamy,
Assistant Professor, Department of Medicine, Jagadguru Sri Shivarathreeshwara Medical College (JSSMC),
JSS University, Mysore, India.
E-mail: drprasannagowda@gmail.com

Abstract

Introduction: Left Ventricular Hypertrophy (LVH) often reflects as a physiological adaptation to chronic pressure overload. It has been identified as a strong independent risk factor of all-cause mortality and adverse cardiac events. Since not all subjects with hypertension develop LVH, understanding the clinical factors contributing to the development of LVH and the appropriate diagnostic and treatment strategies may help clinicians in conducting more definitive evaluation and managing the disease effectively.

Aim: To assess the incidence of LVH in hypertensive subjects and the factors influencing its development and reversal. The study also evaluated the most effective diagnostic technique and therapy that could improve the disease symptoms and prognosis.

Materials and Methods: The prospective study, conducted at Jagadguru Sri Shivarathreeshwara (JSS) Medical College JSS University, Mysore, India, included 50 patients with hypertension. Detailed history of the recruited subjects was collected from patient records and through physical examination. Demographic and clinical characteristics such as age, gender, BMI, and stage of hypertension (stage I HTN and stage II HTN) were also obtained. Funduscopic examination was done for all patients for evidence of hypertensive retinopathy. Echocardiography (ECHO), electrocardiography (ECG), and chest X-Ray were used for detection of LVH. The patients were reviewed after six months and reassessment of LVH was carried out. Statistical analysis was conducted using SPSS software and R 3.2 package.

Results: Angiotensin-Converting Enzyme (ACE) inhibitors were found to be more effective in the treatment of LVH when compared to calcium channel blockers and beta blockers. ECHO was found to be the best method to diagnose LVH. In patients with stage I HTN, 47.1% had normal LVM. Around 53% of the subjects with stage I HTN and all with stage II HTN had abnormal LVM. Retinal changes were noted in 96.2% of abnormal LVM patients and 50% of normal LVM patients. A positive association between BMI and LVH (OR: 1.39) was also noted.

Conclusion: BMI may positively influence LVH regression. The presence of retinopathy, in addition to LVH, suggests an increased chance of regression with anti-hypertensive treatment.

Keywords

Hypertrophy, BMI, Retinopathy, LVM, Echocardiography

How to cite this article :

Prasanna Kumar Hassan Ramaswamy, M. Bhanukumar, Basavanagowdappa Hathur, K.C. Shashidhara, K.M. Srinath . FACTORS CONTRIBUTING TO DEVELOPMENT AND REVERSAL OF LVH: A PILOT STUDY. Journal of Clinical and Diagnostic Research [serial online] 2016 May [cited: 2018 Jan 16 ]; 10:OC17-OC20. Available from
http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2016&month=May&volume=10&issue=5&page=OC17-OC20&id=7767

DOI and Others

DOI: 10.7860/JCDR/2016/19747.7767


Date of Submission: Feb 24, 2016
Date of Peer Review: Mar 21, 2016
Date of Acceptance: Mar 26, 2016
Date of Publishing: May 01, 2016

Financial OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2016: 132.37
  • SCOPUS
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhost
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com